15
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Autoimmune Thrombocytopenia: Anti-Glycoprotein IIb/IIIa Auto Antibodies are Reduced after Human Anti-D Immunoglobulin Treatment

, , , , , & show all
Pages 141-144 | Published online: 07 Jul 2009

References

  • Fchr J, Hoffman V, Kappeler UN. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous immunoglobulin. New Eng. J 1982; 306: 1254–1258
  • Smith NA, Chakraverhty RK, Boughton BJ. The successful treatment of idioptathic thrombocytopenic purpura with the low dose non specific IgG component of anti-D immunoglobulin. Clin. Lab. Haem 1990; 12: 131–136
  • Debre M, Bonnet MC, Fridman WH, Carosella E, Phillippe N, Reihert P, Vilmer E, Kaplan C, Teillaud JC, Griscelli C. Infusion of Fc fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993; 342: 945–949
  • Bierling P, Divine M, Farcet JP, Wallet P, Duedari N. Persistent remission of adult chronic autoimmune thrombocytopenic purpura after treatment with high-dose intravenous immunoglobulin. Amer. J. Haematol 1987; 25: 271–275
  • Atrah HI, Davidson RJL. Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias. J. Clin. Path 1988; 41: 1249–1255
  • Smith NA, Chakraverty RK, Obeid D, Boughton BJ. Long term response in a patient with idiopathic thrombocytopenic purpura following low dose anti-D immunoglobulin treatment. Autoimmunity 1989; 4: 115–117
  • Smith N, Ng JP, Boughton BJ. Prolonged response to nonspecific intramuscular immunoglobulin treatment in patients with ITP. Brit. J. Haematol 1991; 77: 18
  • Rossi F, Kazatchkine MD. Anti-idiotypes against autoantibodies in pooled normal human polyspecific Ig. J. Immunol 1989; 143: 4104–4109
  • Berchtold P, Dale GL, Tani P, McMillan R. Inhibition of autoantibody binding to platelet GPIIb/IIIa by antiidiotype antibodies in intravenous gammaglobulin. Blood 1989; 74: 2414–2417
  • Normura S, Yanabu N, Soga T, Kido H, Fokuroi T, Ya-Maguehi K, Nagata H, Kokawa T, Yasunaga K. Analysis of idiopathic thrombocytopenic purpura patients with anti glycoprotein Ilb/IIIa or lb autoantibodies. Acta Haemato-logica 1991; 86: 25–30
  • Boughton BJ, Chakraverty R, Baglin TB, Simpson A, Galvin G, Rose P, Roholava P. Treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mode of action. Clin, and Lab. Haematol 1988; 10: 275–284
  • Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody specific immobilisation of platelet antigens. (MAIPA). A new tool for the identification of platelet reactive antibodies. Blood 1987; 70: 1722–1726
  • McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL. Platelet associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040–1045
  • Moise K G, Cano LE, Sala DJ. Resolution of severe thrombocytopenia in a pregnant woman with rhesus negative blood and autoimmune thrombocytopenia after intravenous rhesus immunoglobulin. Amer. J. Obstet. Gynaecol 1990; 162: 1237
  • Donnell RL, McMillan R, Yelenosky RJ, Longmire RL, Lightsey AL. Different antiplatelet antibody specificities in immune thrombocytopenic purpura. Brit. J. Haematol 1976; 34: 147–151
  • Beardsley D, Taatjcs H, Lux SE. Target antigens in immune thrombocytopenic purpura. Clin. Res 1984; 32: 494
  • Harris EN, Gharavi AE, Hegde U, Derine G, Morgan SH, Englert H, Chan JKH, Asherson RA, Hughes GRV. anti-cardiolipin antibodies in autoimmune thrombocytopenic purpura. Brit. J. Haematol 1985; 59: 231–234
  • van Vliet HHDM, Kappers-Klunne MC, van der Hel JWB, Abels J. Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura. Brit. J. Haematol 1987; 67: 103–108
  • Tsubakio T, Tani P, Woods VL, Jr, McMillan R. Autoantibodies against platelet GPIIb/IIIa in chronic ITP react with different epitopes. Brit. J. Haematol 1987; 67: 345–348

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.